| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.23B | +16.7% |
| Cost of Revenue | $431.1M | +5.5% |
| Gross Profit | $1.79B | +19.8% |
| R&D Expense | $404.6M | +12.5% |
| SG&A Expense | $524.3M | -12.1% |
| Operating Income | $120.0M | +174.4% |
| Interest Expense | $3.5M | -14.5% |
| Pre-tax Income | $237.1M | +165.7% |
| Income Tax | $19.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $831.0M | -68.0% |
| Short-term Investments | $2.84B | +7992.0% |
| Accounts Receivable | $364.8M | +41.2% |
| Current Assets | $4.14B | +36.1% |
| Total Assets | $4.52B | +30.7% |
| Current Liabilities | $746.0M | +26.9% |
| Total Liabilities | $961.5M | +17.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $712.2M | +218.3% |
| Capital Expenditures | $15.1M | -62.2% |
| Investing Cash Flow | -$2.71B | -5868.2% |
| Financing Cash Flow | $218.8M | +154.5% |
| Free Cash Flow | $697.1M | +279.4% |
| +95.8% |
| Net Income | $209.8M | +156.1% |
| EPS (Basic) | $0.10 | +155.6% |
| EPS (Diluted) | $0.09 | +150.0% |
| Stockholders' Equity |
| $3.48B |
| +35.5% |